(Q77162432)
Statements
Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism (English)
G Buyse
K Waldeck
C Verpoorten
H Björk
P Casaer
1 September 1998
scientific article published on 01 September 1998